Netherlands Hereditary Cancer Testing Market to 2032
Overview
The Netherlands Hereditary Cancer Testing Market is expected to reach a 129.16 USD Million by 2032 and is projected to grow at a CAGR of 17.11% from 2025 to 2032.
Revenue, 2024 (USD Million)
56.67
Forecast, 2032 (USD Million)
129.16
CAGR, 2024 - 2032
17.11%
Report Coverage
Netherlands
Netherlands Hereditary Cancer Testing Market 2018-2032 USD Million
Netherlands Hereditary Cancer Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 56.67 USD Million
- Projected Market Size (2032): 129.16 USD Million
- CAGR (2025-2032): 17.11%
Key Findings of Netherlands Hereditary Cancer Testing Market
- The Netherlands Hereditary Cancer Testing Market was valued at 56.67 USD Million in 2024.
- The Netherlands Hereditary Cancer Testing Market is likely to grow at a CAGR of 17.11% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 38.77 USD Million
- The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 17.97% during the forecast period from 2024 to 2032.
Netherlands Hereditary Cancer Testing Market Scope
Netherlands Hereditary Cancer Testing Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Test
- Single Site Genetic Test
- Multi Panel Test
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Netherlands Hereditary Cancer Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 56.67 USD Million |
| Market Value in 2032 | 129.16 USD Million |
| CAGR (2025-2032) | 17.11% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End Users,Disease,Test,Technology,Diagnosis |
Regional Insights:
-
Leading Market (2024-2032): Netherlands, leading in terms of revenue 56.67 USD Million in 2024
- Key Country: Netherlands, leading in terms of revenue with value of 56.67 USD Million in 2024.
Segments and Scope
-
Netherlands Hereditary Cancer Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 38.77 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.28 % in forecast period 2025-2032.
-
Netherlands Hereditary Cancer Testing Market to 2032, By End Users
- Hospitals is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 21.54 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.97 % in forecast period 2025-2032.
-
Netherlands Hereditary Cancer Testing Market to 2032, By Disease
- Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 32.92 USD Million in the year 2024.
- Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.70 % in forecast period 2025-2032.
-
Netherlands Hereditary Cancer Testing Market to 2032, By Test
- Multi Panel Test is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 37.23 USD Million in the year 2024.
- Multi Panel Test is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.49 % in forecast period 2025-2032.
-
Netherlands Hereditary Cancer Testing Market to 2032, By Technology
- Polymerase Chain Reaction (PCR) is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 36.65 USD Million in the year 2024.
- Polymerase Chain Reaction (PCR) is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.57 % in forecast period 2025-2032.
-
Netherlands Hereditary Cancer Testing Market to 2032, By Diagnosis
- Biopsy is the largest segment in Netherlands Hereditary Cancer Testing Market to 2032 with a revenue of 24.70 USD Million in the year 2024.
- Biopsy is the Fastest growing segment in Netherlands Hereditary Cancer Testing Market to 2032 with a Growth rate of 17.46 % in forecast period 2025-2032.
Netherlands Hereditary Cancer Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| illumina, inc. | |||
| Abbott | |||
| Eurofins Scientific | |||
| LifeLabs Genetics | |||
Netherlands Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Netherlands Hereditary Cancer Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Netherlands Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Disease,Test,Technology,Diagnosis.
Netherlands Hereditary Cancer Testing Market was valued at USD 56.67(Revenue in USD Million) in 2020.
Netherlands Hereditary Cancer Testing Market is projected to grow at a CAGR of 17.11% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Netherlands Hereditary Cancer Testing Market, holding a largest market share of 38.77 USD Million in 2024
Netherlands Hereditary Cancer Testing Market Scope
Netherlands Hereditary Cancer Testing Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Test
- Single Site Genetic Test
- Multi Panel Test
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Frequently Asked Questions
The Netherlands Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Disease,Test,Technology,Diagnosis.
Netherlands Hereditary Cancer Testing Market was valued at USD 56.67(Revenue in USD Million) in 2020.
Netherlands Hereditary Cancer Testing Market is projected to grow at a CAGR of 17.11% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Hereditary Cancer Testing Market for final year is USD 129.16 (USD Million).
Netherlands Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The Netherlands Hereditary Cancer Testing Market is segmented based on Segmentation Distribution Channel,End Users,Disease,Test,Technology,Diagnosis.
Netherlands Hereditary Cancer Testing Market was valued at USD 56.67(Revenue in USD Million) in 2020.
Netherlands Hereditary Cancer Testing Market is projected to grow at a CAGR of 17.11% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Hereditary Cancer Testing Market for final year is USD 129.16 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.